Head Cooling for Stroke
(COOLHEAD-2a Trial)
Recruiting at 1 trial location
MA
WD
Overseen ByWilliam Diprose
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Calgary
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Trial Summary
What is the purpose of this trial?
This is an investigator-initiated, prospective, open-label, single-arm, non-randomized study to assess the safety and feasibility of external active conductive head cooling during endovascular thrombectomy procedures.
Eligibility Criteria
This trial is for patients experiencing an acute ischemic stroke who are scheduled to undergo a procedure called endovascular thrombectomy. It's not open to individuals outside of this group.Inclusion Criteria
I am scheduled for a procedure to remove a clot due to a stroke.
Timeline
Screening
Participants are screened for eligibility to participate in the trial
1-2 weeks
Treatment
Participants undergo external active conductive head cooling during endovascular thrombectomy procedures
From time of application in the emergency department until the end of the endovascular thrombectomy procedure
Follow-up
Participants are monitored for safety and effectiveness after treatment
4 weeks
Treatment Details
Interventions
- External active conductive head cooling
Trial Overview The study is testing the safety and how doable it is to use external active conductive head cooling on patients during their clot removal procedure for stroke.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Treatment armExperimental Treatment1 Intervention
Head cooling
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Calgary
Lead Sponsor
Trials
827
Recruited
902,000+
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.